Long‐term outcomes after re‐entry device use for recanalization of common iliac artery chronic total occlusions
Damianos G. Kokkinidis(Memorial Hospital of South Bend), Ehrin J. Armstrong(University of Denver), T. Raymond Foley(Lancaster General Hospital), Prio Hossain(University of California, Davis), Stephen W. Waldo(United States Department of Veterans Affairs), Ryan Cotter(Denver VA Medical Center), Bejan Alvandi(University of Utah), Gagan D. Singh(University of California, Davis), John R. Laird(St. Helena Hospital)
Cited by 17
Related Papers
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity
|JAMA Cardiology|2019|418
Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
|Journal of the American Heart Association|2014|243
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
|Cancer Prevention Research|2009|193